A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg

NCT00305448 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Fulvestrant
DRUG: Fulvestrant

Sponsor

AstraZeneca